Literature DB >> 10822058

Activation of G protein by opioid receptors: role of receptor number and G-protein concentration.

A E Remmers1, M J Clark, A Alt, F Medzihradsky, J H Woods, J R Traynor.   

Abstract

The collision-coupling model for receptor-G-protein interaction predicts that the rate of G-protein activation is dependent on receptor density, but not G-protein levels. C6 cells expressing mu- or delta-opioid receptors, or SH-SY5Y cells, were treated with beta-funaltrexamine (mu) or naltrindole-5'-isothiocyanate (delta) to decrease receptor number. The time course of full or partial agonist-stimulated ¿35SGTPgammaS binding did not vary in C6 cell membranes containing <1-25 pmol/mg mu-opioid receptor, or 1. 4-4.3 pmol/mg delta-opioid receptor, or in SHSY5Y cells containing 0. 16-0.39 pmol/mg receptor. The association of ¿35SGTPgammaS binding was faster in membranes from C6mu cells than from C6delta cells. A 10-fold reduction in functional G-protein, following pertussis toxin treatment, lowered the maximal level of ¿35SGTPgammaS binding but not the association rate. These data indicate a compartmentalization of opioid receptors and G protein at the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822058     DOI: 10.1016/s0014-2999(00)00212-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.

Authors:  A Alt; M J Clark; J H Woods; J R Traynor
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Membrane functional organisation and dynamic of mu-opioid receptors.

Authors:  André Lopez; Laurence Salomé
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

3.  Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.

Authors:  M M Doat-Meyerhoefer; R Hard; J C Winter; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

4.  High- and low-affinity sites for sodium in δ-OR-Gi1α (Cys (351)-Ile (351)) fusion protein stably expressed in HEK293 cells; functional significance and correlation with biophysical state of plasma membrane.

Authors:  Miroslava Vošahlíková; Piotr Jurkiewicz; Lenka Roubalová; Martin Hof; Petr Svoboda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-01       Impact factor: 3.000

5.  Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?

Authors:  Christopher J Brinkerhoff; John R Traynor; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2008-08-08       Impact factor: 2.691

6.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.

Authors:  Kenneth G Holden; Kevin Tidgewell; Alfred Marquam; Richard B Rothman; Hernán Navarro; Thomas E Prisinzano
Journal:  Bioorg Med Chem Lett       Date:  2007-09-15       Impact factor: 2.823

7.  Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa.

Authors:  De Wayne Townsend; David R Brown
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

8.  High Efficacy but Low Potency of δ-Opioid Receptor-G Protein Coupling in Brij-58-Treated, Low-Density Plasma Membrane Fragments.

Authors:  Lenka Roubalova; Miroslava Vosahlikova; Jana Brejchova; Jan Sykora; Vladimir Rudajev; Petr Svoboda
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

9.  Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor.

Authors:  Kathryn E Livingston; Jacob P Mahoney; Aashish Manglik; Roger K Sunahara; John R Traynor
Journal:  Elife       Date:  2018-06-22       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.